Charles Schwab Investment Management Inc Cognition Therapeutics Inc Transaction History
Charles Schwab Investment Management Inc
- $601 Billion
- Q3 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 84,940 shares of CGTX stock, worth $131,657. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84,940Holding current value
$131,657% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding CGTX
# of Institutions
77Shares Held
22.9MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$9.3 Million9.11% of portfolio
-
Davenport & CO LLC2.69MShares$4.17 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.68MShares$4.16 Million0.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$3.42 Million0.02% of portfolio
-
Tang Capital Management LLC San Diego, CA1.2MShares$1.86 Million0.07% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $35.2M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...